Science Fair Project Encyclopedia
Oregon Ballot Measure 33 (2004)
Ballot Measure 33 of 2004 would have expanded Oregon's medical marijuana law , allowing the creation of nonprofit marijuana dispensaries which could sell marijuana to patients, and increasing the maximum amount of marijuana that patients may possess. Voters rejected the measure in the 2 November 2004 general election, with 764,015 votes in favor, and 1,021,814 votes against. It was placed on the ballot by initiative petition.
Oregon law allows registered patients to possess and produce limited amounts of marijuana for medical purposes. (Patients must obtain a permit and a doctor's statement that they suffer from a "debilitating medical condition and that the medical use of marijuana may mitigate the symptoms or effects of the person's debilitating medical condition .") The law does not allow a patient to purchase marijuana for medical purposes, however.
Measure 33 would have expanded the law, allowing the creation of nonprofit state-licensed dispensaries, that could produce the drug and sell it to patients. The dispensaries would have been required to provide the drug to indigent patients for free. If, after six months of the measure's passage, a county lacked a dispensary, the county health division would have been granted a license to open a dispensary.
Supporters of Measure 33 claimed that the current prohibition on marijuana sales to patients hindered their ability to obtain the quantities they need for treatment. They viewed this measure as a responsible solution to that problem. Some opponents argued that the measure was a back door legalization attempt. Some also feared that this expansion would have attracted the ire of the federal government, who would have attempted to shut down the entire Oregon medical marijuana program.
- Oregon Voter's Guide page for Measure 33--includes ballot title , text of the measure, and arguments for and against
The contents of this article is licensed from www.wikipedia.org under the GNU Free Documentation License. Click here to see the transparent copy and copyright details